These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26121319)

  • 41. Elevated expression of KLK8 predicts poor prognosis in colorectal cancer.
    Liu X; Quan B; Tian Z; Xi H; Jia G; Wang H; Zhang L; Liu R; Ma C; Han F; Li H; Yuan F
    Biomed Pharmacother; 2017 Apr; 88():595-602. PubMed ID: 28142115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced SULT2B1b expression alleviates ox-LDL-induced inflammation by upregulating miR-148-3P via inhibiting the IKKβ/NF-κB pathway in macrophages.
    Yin M; Lu J; Guo Z; Zhang Y; Liu J; Wu T; Guo K; Luo T; Guo Z
    Aging (Albany NY); 2021 Jan; 13(3):3428-3442. PubMed ID: 33428590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLJ1 is a novel biomarker for colorectal carcinoma progression and overall patient survival.
    Liu Y; Zhou J; Zhang C; Fu W; Xiao X; Ruan S; Zhang Y; Luo X; Tang M
    Int J Clin Exp Pathol; 2014; 7(3):969-77. PubMed ID: 24696714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of CIP2A and its mechanism of action in the malignant biological behavior of colorectal cancer.
    Chen W; Liang JL; Zhou K; Zeng QL; Ye JW; Huang MJ
    Cell Commun Signal; 2020 Apr; 18(1):67. PubMed ID: 32321509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway.
    Sun Y; Ji B; Feng Y; Zhang Y; Ji D; Zhu C; Wang S; Zhang C; Zhang D; Sun Y
    Oncol Rep; 2017 Jul; 38(1):43-52. PubMed ID: 28534983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.
    Xu X; Chang W; Yuan J; Han X; Tan X; Ding Y; Luo Y; Cai H; Liu Y; Gao X; Liu Q; Yu Y; Du Y; Wang H; Ma L; Wang J; Chen K; Ding Y; Fu C; Cao G
    Oncotarget; 2016 Jan; 7(1):798-813. PubMed ID: 26556874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in colorectal cancer.
    Chen P; Xi Q; Wang Q; Wei P
    Med Oncol; 2014 Oct; 31(10):235. PubMed ID: 25216869
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
    Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
    Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression and clinical significance of absent in melanoma 2 in colorectal cancer.
    Zhang Z; Dong X; Yang X; Wan D; Sun L; Gu M; Li M; Zhu Z; Wang J; Shang Z; He S
    Biomed Pharmacother; 2017 Oct; 94():843-849. PubMed ID: 28802238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.
    Igarashi H; Taniguchi H; Nosho K; Ishigami K; Koide H; Mitsuhashi K; Okita K; Takemasa I; Imai K; Nakase H
    Clin Transl Oncol; 2020 Jul; 22(7):1126-1137. PubMed ID: 31741141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between miRNA-338-3p expression and progression and prognosis of human colorectal carcinoma.
    Sun K; Su G; Deng H; Dong J; Lei S; Li G
    Chin Med J (Engl); 2014; 127(10):1884-90. PubMed ID: 24824250
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth.
    Zhang N; Zhang R; Zou K; Yu W; Guo W; Gao Y; Li J; Li M; Tai Y; Huang W; Song C; Deng W; Cui X
    Cell Death Dis; 2017 Jul; 8(7):e2961. PubMed ID: 28749462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of SATB1 promotes the growth and metastasis of colorectal cancer.
    Zhang Y; Tian X; Ji H; Guan X; Xu W; Dong B; Zhao M; Wei M; Ye C; Sun Y; Yuan X; Yang C; Hao C
    PLoS One; 2014; 9(6):e100413. PubMed ID: 24971456
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells.
    Ma K; Pan X; Fan P; He Y; Gu J; Wang W; Zhang T; Li Z; Luo X
    Mol Cancer; 2014 May; 13():118. PubMed ID: 24885288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytosolic sulfotransferase 2B1b promotes hepatocyte proliferation gene expression in vivo and in vitro.
    Zhang X; Bai Q; Xu L; Kakiyama G; Pandak WM; Zhang Z; Ren S
    Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(3):G344-55. PubMed ID: 22679001
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET.
    Wang S; Qiu J; Liu L; Su C; Qi L; Huang C; Chen X; Zhang Y; Ye Y; Ding Y; Liang L; Liao W
    J Exp Clin Cancer Res; 2020 Aug; 39(1):168. PubMed ID: 32843066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro.
    Zhou W; Li X; Liu F; Xiao Z; He M; Shen S; Liu S
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):838-46. PubMed ID: 23017832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of miR-223 correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.
    Li ZW; Yang YM; Du LT; Dong Z; Wang LL; Zhang X; Zhou XJ; Zheng GX; Qu AL; Wang CX
    Med Oncol; 2014 Nov; 31(11):256. PubMed ID: 25270282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.